FDA Clears GSK's Combo Vaccine For Kids
This article was originally published in The Pink Sheet Daily
Executive Summary
Four-in-one shot means fewer needle sticks, same protection.
You may also be interested in...
GSK Sees Progress On Three Regulatory Filings
FDA accepts BLA for combination pediatric vaccine and grants priority review for an oral form of Hycamtin for SCLC.
Another Hybrid License Deal: Chiesi Buys Majority Stake In Cornerstone
In a creative deal that echoes the strategic tie-up last year between Infinity and Mundipharma, Italian giant Chiesi Farmaceutici is buying a majority stake in Cornerstone Therapeutics, which gets $15.5 million along with U.S. rights for 10 years to Chiesi's marketed lung surfactant Curosurf
Another Hybrid License Deal: Chiesi Buys Majority Stake In Cornerstone
With a would-be competitor from Discovery Labs stalled at FDA, approved lung surfactant Curosurf sits at the center of equity, cash tie-up.